News Archives - Page 2 of 2 - VIPOC

News

7 March 2024

VStrong Incyte 2023 Inguinity awards winner

Wow, what incredible news! The selection committee has awarded the…

Marketing 0

Love0

News

8 December 2023

Vitiligo and Us Comic Book

The French Vitiligo Association is delighted to unveil its inaugural…

Marketing 0

Love0

News

23 November 2023

Doctors’ training on vitiligo in the D.R.C

The Association Franco-Congolaise du Vitiligo (AFCV), which was created in…

Marketing 0

Love0

- Study phase 2 Abbvie -UPADACITINIB News

20 October 2023

Upadacitinib Meets Primary End Point of Phase 2 Trial for Vitiligo and Advances to Phase 3

AbbVie recently announced that its phase 2b study investigating upadacitinib (Rinvoq)…

Marketing 0

Love0

News

18 May 2023

New therapy for vitiligo patients

For a long time, vitiligo was considered purely a cosmetic…

VIPOC 0

Love0

News

22 April 2023

Incyte Announces European Commission Approval Of Opzelura® (Ruxolitinib) Cream For The Treatment Of Non-Segmental Vitiligo With Facial Involvement In Adults And Adolescents

April 20, 2023 at 10:21 AM EDT Opzelura® (ruxolitinib) Cream is…

VIPOC 0

Love0

News

3 March 2023

The first step for a medicinal product for vitiligo has been authorized in Europe

On February 23, 2023, the European Medicines Agency (EMA) published…

VIPOC 0

Love0

News

1 November 2022

VIPOC Appoints Mrs. Gaone Matewa As New President

…

VIPOC 0

Love0

News

9 June 2022

3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS)

50 attendees - 20 nations 20 leaders of vitiligo organizations…

VIPOC 0

Love0

© 2025 VIPOC. Copyright © VIPOC Built by Simboti Digital All rights reserved.|Privacy Policy - English|Privacy Policy - French